Literature DB >> 17506473

Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study.

L A Tortajada-Genaro1, M P Cózar, J L Moreno Frigols, C Romero de Avila.   

Abstract

In this study we compared and validated commercial immunoradiometric assays (IRMA) to determine thyroglobulin (Tg) levels in serum. From a set of 440 samples, 68 were selected to calculate the validation parameters and the clinical performance of the assays. The commercial kits evaluated were the Tg-CTK (DiaSorin), IRMAZenco Tg (ZenTech), and SELco-Tg (Medipan). We found that 21% of the collected samples were in the critical range of concentration. Detection limits were calculated as being below 3 microg/L. Intra- and inter-reproducibility were lower than 3.1% and 9.2%, respectively. Dilution and recovery studies provided quantitative determinations. Correlation regression coefficients from the results of the methods were obtained. The determined concentrations were compared with the clinical evidence of disease. Variation in the 125-iodine-labeled antibody concentration and control charts showed the robustness of the methods. Analysis time and the simplicity of the methods were also evaluated. Reliable Tg determination is important for monitoring patients with differentiated thyroid cancer (DTC), controlling other thyroid diseases, and assessing the quality of imaging techniques. A strategy for verification and comparison based on analytical parameters and clinical performance is proposed. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506473      PMCID: PMC6648971          DOI: 10.1002/jcla.20156

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  15 in total

1.  Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease.

Authors:  Catherine Massart; Didier Maugendre
Journal:  Clin Chem       Date:  2002-01       Impact factor: 8.327

2.  High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.

Authors:  L Giovanella; L Ceriani; S Garancini
Journal:  Q J Nucl Med       Date:  2002-12

3.  Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.

Authors:  Martin Schlumberger; Furio Pacini; Wilmar M Wiersinga; Antony Toft; Johannes W A Smit; Franco Sanchez Franco; Peter Lind; Edward Limbert; Barbara Jarzab; François Jamar; Leonidas Duntas; Ohad Cohen; Gertrud Berg
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

4.  Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.

Authors:  L Ferrari; E Seregni; G Aliberti; A Martinetti; F Pallotti; C Villano; G Lucignani; E Bombardieri
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-09       Impact factor: 2.346

5.  [F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan].

Authors:  J V Ruiz Franco-Baux; I Borrego Dorado; P Gómez Camarero; J R Rodríguez Rodríguez; R J Vázquez Albertino; E Navarro González; R Astorga Jiménez
Journal:  Rev Esp Med Nucl       Date:  2005 Jan-Feb

6.  Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas.

Authors:  C A Spencer; L M Bergoglio; M Kazarosyan; S Fatemi; J S LoPresti
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

7.  Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery.

Authors:  Onyebuchi E Okosieme; Carol Evans; Laura Moss; Arthur B Parkes; L D Kuvera E Premawardhana; John H Lazarus
Journal:  Clin Chem       Date:  2005-02-03       Impact factor: 8.327

8.  Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?

Authors:  Francesco Giammarile; Zakia Hafdi; Claire Bournaud; Marc Janier; Claire Houzard; Claude Desuzinges; Roland Itti; Genevieve Sassolas; Francoise Borson-Chazot
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

9.  Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.

Authors:  F Bourrel; M Hoff; H Regis; P Courrière; P Caron
Journal:  Clin Chem Lab Med       Date:  1998-09       Impact factor: 3.694

10.  Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies.

Authors:  P Y Marquet; A Daver; R Sapin; B Bridgi; J P Muratet; D J Hartmann; F Paolucci; B Pau
Journal:  Clin Chem       Date:  1996-02       Impact factor: 8.327

View more
  4 in total

1.  Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?

Authors:  Sohyun Park; Ji-In Bang; Ho-Young Lee; Sang-Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2015-01-27

2.  Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.

Authors:  Marijana Stanojevic; Svetlana Savin; Dubravka Cvejic; Aleksandar Djukic; Marija Jeremic; Snezana Zivancević Simonovic
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake.

Authors:  Zhaojun Wang; Hanyi Zhang; Xiaowen Zhang; Jie Sun; Cheng Han; Chenyan Li; Yongze Li; Xiaochun Teng; Chenling Fan; Aihua Liu; Zhongyan Shan; Chao Liu; Jianping Weng; Weiping Teng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

4.  Laboratory reproducibility of biochemical markers of bone turnover in clinical practice.

Authors:  A L Schafer; E Vittinghoff; R Ramachandran; N Mahmoudi; D C Bauer
Journal:  Osteoporos Int       Date:  2009-06-09       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.